A new statistical procedure for testing equivalence in two-group comparative bioavailability trials
- 459 Downloads
The clinical problem of testing for equivalence in comparative bioavailability trials is restated in terms of the proper statistical hypotheses. A simple t-test procedure for these hypotheses has been devloped that is more powerful than the methods based on usual (shortest) and symmetric confidence intervals. In this note, this new procedure is explained and an example is given, including the method for sample size determination.
Key wordsbioavailability bioequivalence hypothesis tests sample size determination
Unable to display preview. Download preview PDF.
- 7.D. J. Schuirmann. Fixed sample tests for interval hypotheses associated with bioequivalence trials. Presented at Joint Statistical Meetings, Cincinnati, August, 1982.Google Scholar
- 10.W. J. Westlake. The design and analysis of comparative blood-level trials. In J. Swarbrick (ed),Current Concepts in the Pharmaceutical Sciences, Dosage Form Design and Bioavailability, Lea & Febiger, Philadelphia, 1973, pp. 149–179.Google Scholar
- 12.W. J. Westlake. Design and statistical evaluation of bioequivalence studies in man. In J. Blanchard, R. W. Sawchuk, and B. B. Brodie (ed),Principles and Perspectives in Drug Bioavailability, Karger, Basel, 1979, pp. 192–210.Google Scholar
- 13.W. J. Westlake. Response to bioequivalence testing—a need to rethink.Biometrics 37: 591–593 (1981).Google Scholar
- 15.Food and Drug Administration. The bioavailability protocol guideline for ANDA and NDA submission. Division of Biopharmaceutics, Drug Monographs/Bureau of Drugs, Food and Drug Administration, 1977.Google Scholar